Maya Williams1, Ian Todd1, Lucy C Fairclough2. 1. School of Life Sciences, The University of Nottingham, Life Sciences Building, University Park, Nottingham, NG7 2RD, UK. 2. School of Life Sciences, The University of Nottingham, Life Sciences Building, University Park, Nottingham, NG7 2RD, UK. lucy.fairclough@nottingham.ac.uk.
Abstract
OBJECTIVE AND DESIGN: This systematic review aims to establish the role of CD8 + T lymphocytes in COPD. METHODS: Forty-eight papers published in the last 15 years were identified for inclusion. RESULTS: CD8 + T-cells are increased in the lungs of patients with COPD (17 studies, 16 positive) whereas in the circulation, findings were inconclusive. Activation of CD8 + T-cells was enhanced in lungs (four studies, three positive) but cell phenotype was unclear. There was substantial evidence of a higher proportion of type 1 CD8 + (Tc1) cells in COPD (11 studies, 9 positive), though the population of type 2 (Tc2) cells was also increased (5 studies, 4 positive). CD8 + T-cells in COPD exhibited greater expression of cytotoxic proteins (five studies, five positive). Studies assessed a variety of questions so evidence was insufficient to draw firm conclusions. The role of CD8 + T-cells at acute exacerbation of COPD and also their contribution to alveolar destruction can only be hypothesised at this stage. CONCLUSIONS: Not only is the number of CD8 + T-cells increased in COPD, these cells have increased capacity to exert effector functions and are likely to contribute to disease pathogenesis. Several mechanisms highlighted show promise for future investigation to consolidate current knowledge.
OBJECTIVE AND DESIGN: This systematic review aims to establish the role of CD8 + T lymphocytes in COPD. METHODS: Forty-eight papers published in the last 15 years were identified for inclusion. RESULTS:CD8 + T-cells are increased in the lungs of patients with COPD (17 studies, 16 positive) whereas in the circulation, findings were inconclusive. Activation of CD8 + T-cells was enhanced in lungs (four studies, three positive) but cell phenotype was unclear. There was substantial evidence of a higher proportion of type 1 CD8 + (Tc1) cells in COPD (11 studies, 9 positive), though the population of type 2 (Tc2) cells was also increased (5 studies, 4 positive). CD8 + T-cells in COPD exhibited greater expression of cytotoxic proteins (five studies, five positive). Studies assessed a variety of questions so evidence was insufficient to draw firm conclusions. The role of CD8 + T-cells at acute exacerbation of COPD and also their contribution to alveolar destruction can only be hypothesised at this stage. CONCLUSIONS: Not only is the number of CD8 + T-cells increased in COPD, these cells have increased capacity to exert effector functions and are likely to contribute to disease pathogenesis. Several mechanisms highlighted show promise for future investigation to consolidate current knowledge.
Entities:
Keywords:
CD8 + T lymphocyte; Chronic obstructive pulmonary disease; Cytotoxic T cell; Lung disease; Smoking
Authors: Helena Forsslund; Mikael Mikko; Reza Karimi; Johan Grunewald; Åsa M Wheelock; Jan Wahlström; C Magnus Sköld Journal: Chest Date: 2014-04 Impact factor: 9.410
Authors: Jordi Olloquequi; Jaume Ferrer; Juan F Montes; Esther Rodríguez; M Angeles Montero; José García-Valero Journal: Respir Med Date: 2010-03-31 Impact factor: 3.415
Authors: Liboria Siena; Mark Gjomarkaj; John Elliot; Elisabetta Pace; Andreina Bruno; Simonetta Baraldo; Marina Saetta; Maria Rosaria Bonsignore; Alan James Journal: Respir Med Date: 2011-05-25 Impact factor: 3.415
Authors: Mathew S Eapen; Kielan McAlinden; Daniel Tan; Steven Weston; Chris Ward; Hans K Muller; Eugene H Walters; Sukhwinder S Sohal Journal: Respirology Date: 2017-03-22 Impact factor: 6.424
Authors: Magnus J Löfdahl; Ester Roos-Engstrand; Jamshid Pourazar; Anders Bucht; Barbro Dahlen; Göran Elmberger; Anders Blomberg; C Magnus Sköld Journal: Respir Med Date: 2008-08-15 Impact factor: 3.415
Authors: Xin Sun; Anne-Karina Perl; Rongbo Li; Sheila M Bell; Eniko Sajti; Vladimir V Kalinichenko; Tanya V Kalin; Ravi S Misra; Hitesh Deshmukh; Geremy Clair; Jennifer Kyle; Laura E Crotty Alexander; Jorge A Masso-Silva; Joseph A Kitzmiller; Kathryn A Wikenheiser-Brokamp; Gail Deutsch; Minzhe Guo; Yina Du; Michael P Morley; Michael J Valdez; Haoze V Yu; Kang Jin; Eric E Bardes; Jarod A Zepp; Terren Neithamer; Maria C Basil; William J Zacharias; Jamie Verheyden; Randee Young; Gautam Bandyopadhyay; Sara Lin; Charles Ansong; Joshua Adkins; Nathan Salomonis; Bruce J Aronow; Yan Xu; Gloria Pryhuber; Jeff Whitsett; Edward E Morrisey Journal: Dev Cell Date: 2021-12-21 Impact factor: 13.417
Authors: Wenxin Wu; Lili Tian; Wei Zhang; J Leland Booth; Erola Ainsua-Enrich; Susan Kovats; Brent R Brown; Jordan P Metcalf Journal: Respir Res Date: 2021-04-20
Authors: Lena Lundh; Kjell Larsson; Anders Lindén; Scott Montgomery; Lena Palmberg; Hanna Sandelowsky Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-05-02
Authors: Kaschin Jamal Jameel; Willem-Jakob Gallert; Sarah D Yanik; Susanne Panek; Juliane Kronsbein; David Jungck; Andrea Koch; Jürgen Knobloch Journal: Int J Mol Sci Date: 2021-07-02 Impact factor: 5.923
Authors: Rubina Bunjun; Andreia P Soares; Narjis Thawer; Tracey L Müller; Agano Kiravu; Zekarias Ginbot; Björn Corleis; Brandon D Murugan; Douglas S Kwon; Florian von Groote-Bidlingmaier; Catherine Riou; Robert J Wilkinson; Gerhard Walzl; Wendy A Burgers Journal: Front Immunol Date: 2021-06-30 Impact factor: 7.561